Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
Breast cancer screening global approaches
Modified radical mastectomy
Management of surgical complications in thyroid surgery
Cost-benefit analysis of new cancer medicines: The difficult choices of governments
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
Epitope editing enables targeted immunotherapy of acute myeloid leukaemia
OncoAlert Round Up for September 22-28, 2023
OncoAlert Round Up for September 15-21, 2023
OncoAlert Round Up for September 8-14, 2023
Treating cancer in the heart of the Ukraine conflict